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Adiposity is associated with elevated blood glucose levels, insulin resistance, and is a risk 49 factor for the development of type 2 diabetes [1] [2] [3] [4] . Moreover, weight gain over a period of 50 several years is associated with elevated blood glucose, insulin resistance, and increased risk 51 of diabetes [1, 5] . Conversely, weight loss can improve glycaemic control and insulin 52 sensitivity in individuals with or without diabetes [6, 7] . Current or momentary weight (e.g. 53 weight measured at any given point in time) and preceding weight change can have 54 simultaneous, independent effects on cardiovascular risk outcomes [8] , hypertension [9] , and 55 insulin and glucose metabolism [10] [11] [12] . However, the extent to which momentary Body 56
Mass Index (BMI, kg/m 2 ) interacts with BMI change trajectories and predicts insulin 57 secretion and sensitivity has not yet been clearly established. 58
59
Generalizability of extant research on this topic is limited by sample (e.g. solely women in 60
Jernström and Barratt-Conner [10] ; solely obese individuals in Sjöholm et al. [12] ) or 61 operationalisation of glucose and insulin metabolism (e.g. only fasting insulin in Norman et 62 al. [11] ). Yet, taken together, they suggest that weight change over a number of years may 63 M A N U S C R I P T
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Weight change glucose insulin Walsh, Shaw, Cherbuin 8 more blood glucose measures >5.6mmol/L), or NFG (not type 2 diabetes or IFG, and two or 124 more blood glucose measures <5.6) [21] . Physical activity was measured in term of 125 Metabolic Equivalents (METs), from self-reported hours spent engaging physical using the 126 formula (hours mild PA×3)+(hours moderate PA×6)+(hours vigorous PA×9) [22] . 127 128
Statistical analyses 129
All analyses were carried out in R version 3.2.0. α was set at 0.05. Sampling bias 130 (selected/not selected) and drop out (measures available/not available at final wave) were 131 investigated with t and chi square tests. Possible multivariate outliers were detected via 132
Mahalanobis distances exceeding 20 (chi square cut-off at α=0.05, at 11 degrees of freedom 133 for 5 DVs, 2 IVs, and covariates). 134
135
Missingness 136
There was no missingness in insulin, and 2.02% of BMI data were missing (though no more 137 than one missing occasion for each participant). Of a total of 2128 data points (532 138 participants x four measurement occasions), <1% of covariate data was missing. To preserve 139 sample size, this missing data in covariates was singly imputed in SPSS version 22, EM at 140 1000 iterations. 141
142
Trajectories 143 A latent class model was used to estimate mutually exclusive classes of BMI change over 144 time. Exploratory modelling and the Bootstrap Likelihood Ratio Test (BLRT) were used to 145 establish the appropriate number of classes (2, 3, 4, or 5) and link function (linear, or beta), 146 using the packages mclust (version 5.2) and lcmm (version 1.7.5). 147 M A N U S C R I P T
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Multivariate generalised linear models 149
Multivariate generalised linear models were applied to account relatedness between the 150 outcome measures. Plasma glucose, plasma insulin, HOMA2-IR, HOMA2-%β and HOMA2-151 %S were specified as outcome variables, and follow-up BMI, BMI class, and covariates were 152 specified as predictors. If multivariate significance (indicated by F-statistic derived from the 153 Pillai-Bartlett Trace) was achieved, general linear models for each outcome were computed. 154
Three models were fit: (1) the impact of BMI (at wave 4) on outcomes, (2) the impact of 155 trajectory on plasma glucose, insulin, HOMA2-IR, HOMA2-%β and HOMA2-%S, then (3) 156 the interaction between BMI (at wave 4) and trajectory on plasma glucose, insulin, HOMA2-157 IR, HOMA2-%β and HOMA2-%S. 158
159
Results
160
Participant characteristics are displayed in Table 1 . t and χ 2 tests revealed no significant 161 difference between selected/not selected in gender, physical activity, blood glucose at wave 162 4, or hypertension. However those included were significantly older (t(667.419)=-4.224, 163 p<0.05 (M=53 vs M=55)). Latent class analysis resulted in four BMI trajectories which are 164 henceforth referred to as constant normal, constant high, increase, and decrease (summarised 165 in Figure 1 ) as these best described the patterns of change observed. It should be noted 166 however that "constant normal" does include a minority of participants who over the follow-167 up can be categorised as overweight but since sensitivity analyses (see below) indicate that 168 these participants did not meaningfully influence the pattern of results they were kept in this 169 group to maintain the integrity of the analytical approach used. Figure 2 and reported in Table 2 . In both cohorts, higher BMI at wave 4 was 189 significantly associated with higher plasma insulin at wave 4, increased insulin resistance at 190 wave 4, higher beta cell function, and lower insulin sensitivity (Table 3) . 191
192
Constant high trajectory 193
In the 40s cohort, the constant high trajectory was associated with significantly higher plasma 194 insulin (M=27.74 µlU/ml vs M=16.63 µlU/ml) insulin resistance (M=3.51% vs M=2.02%), 195 and beta cell function (M=131.55% vs M=102.09%), than constant normal. In fully adjusted 196 models, at any given BMI, plasma insulin was 107% higher (p<0.01), insulin resistance 197 104% greater (p<0.01), and beta cell function 28% higher (p<0.01) if preceded by high rather 198 than normal trajectory. Preceding trajectory also significantly interacted with current BMI for 199 these outcomes, such that the impact of each unit of BMI was 20% greater on plasma insulin 200 M A N U S C R I P T
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Weight change glucose insulin Walsh, Shaw, Cherbuin 11 (p=0.01) and 19% greater on insulin resistance (p=0.02) in the constant high than in the 201 constant normal trajectory. In the 60s cohort, the constant high trajectory was significantly 202 associated with higher plasma insulin (M=19.84 µlU/ml vs M=12.62 µlU/ml) and insulin 203 resistance (M=2.73% vs M=1.61%), such that, in fully adjusted models and at any given 204 BMI, plasma insulin was 40% higher (p=0.01), and insulin resistance 40% greater (p=0.03) if 205 preceded by high rather than normal trajectory. There was a significant interaction between 206 BMI and plasma glucose, such that those in the constant high trajectory experienced 0.12 207 mmol/L lower blood glucose associated with each unit increase in BMI. 208
209
Decrease trajectory 210
In the 40s cohort, the decrease trajectory alone was not significantly associated with any 211 blood measure, but preceding trajectory significantly interacted with BMI, such that the 212 impact of each unit of BMI was 11% less (p=0.02) on plasma insulin, 10.92% less (p=0.02) 213 on insulin resistance, and 4% less beta cell function (p=0.01) relative to constant normal 214 trajectory. In the 60s cohort, there were no significant differences between the decrease and 215 constant normal trajectories. However, individuals in the decrease trajectory had significantly 216 better outcomes (e.g. lower plasma glucose, insulin resistance, etc.) when compared to the 217 constant high trajectory (40s Pillai= 0. 
Sensitivity analysis 235
Potential bias from covariates was investigated by fitting multiple models from unadjusted to 236 fully adjusted (age, gender, physical activity, impaired fasting glucose, and hypertension) 237 and excluding potential multivariate outliers (11 excluded from 40s, 17 excluded from 60s). 238
As summarised in supplementary figures D and E, coefficient directionality and significance 239 was generally consistent. The pattern of significance across models in the 40s indicates that 240 the significant association between BMI and plasma glucose may be due to outliers (as it is 241 not significant in an unadjusted model, or where outliers are excluded). Further analyses 242 were conducted for a broader sample that included individuals with T2D, adding 13 243 individuals to the 40s, and 62 individuals to the 60s cohorts thus increasing the total sample 244 size to 607. Results (including trajectories and multivariate results) were very similar (see 245 supplementary materials for further details). While all individuals in the constant high 246 trajectory had BMI > 30 at all times, due to some waves with BMI increase followed by 247 decrease the next wave, there was some overlap in range with the constant normal 248 trajectories (43 individuals in the 40s and 38 in the 60s in the constant normal trajectory have 249 a BMI > 30 at one or more points). Analyses were repeated with these individuals excluded. 250
Coefficient direction, magnitude, and significance was unaffected by this. Although biological models would predict that weight loss in the context of obesity should 294 be associated with decreased insulin secretion, some studies have indicated that obesity-295 related insulin hypersecretion continues after weight loss [15] . Our investigation of 296 community-living adults followed over a decade (rather than, for example, individuals 297 immediately following post-bariatric surgery) found no main effect difference between the 298 weight loss and constant normal trajectories. Despite their weight loss over time, individuals 299 in the weight loss trajectory tended to be obese at baseline and still had higher BMI 300
(averaging on the border of overweight/obese) at final follow-up when compared with thoseM A N U S C R I P T addressed this by examining a large community-living sample, and multiple trajectories of 311 weight change measured in the same timeframe. Although generalizability may be limited 312 due to selection effects in PATH and the current sub-sample, self-reported weight in the 313 current study is commensurate with national measures [29] . 314
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The primary limitation was the use of BMI from self-report as a measure of body weight, 316 rather than the body fat mass. Individuals typically under-report weight, but this does not 317 threaten conclusions because of the focus on within-subject change. Although BMI is used 318 extensively as a proxy for adiposity [30] , it cannot provide information about the proportion 319 of fat to muscle mass, which can influence the association between overall body weight and 320 insulin metabolism [15] . Accordingly, further research could build on current findings by 321 calculating weight trajectories from biomarkers such as leptin. 322
323
The objective of this study was to examine the relationship between trajectories of weight 324 change over twelve years and blood glucose and insulin functioning in a sample of both 325 diabetic and non-diabetic community-living middle aged and elderly adults, spanning theM A N U S C R I P T
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Weight change glucose insulin Walsh, Shaw, Cherbuin 16 normal weight range. Results support the assertion that the trajectory of preceding weight 327 change has a simultaneous, independent, and clinically meaningful effect on blood glucose 328 metabolism beyond body weight measured at any given point in time. Significance indicates that some or all of the outcomes are significantly associated with 434 predictors, even when correlation between outcomes is accounted for. Three models were fit: 435
(1) the impact of BMI (at wave 4) on outcomes, (2) the impact of trajectory on outcomes, 436 then (3) the interaction between BMI (at wave 4) and trajectory on outcomes. All models 437 M A N U S C R I P T 
